<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04493112</url>
  </required_header>
  <id_info>
    <org_study_id>Sequent Please NEO</org_study_id>
    <nct_id>NCT04493112</nct_id>
  </id_info>
  <brief_title>SeQuent Please Neo Multicenter Registry</brief_title>
  <official_title>SeQuent Please Neo Multicenter Registry / Registro Multicéntrico Sequent Please NEO</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Germans Trias i Pujol Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The registry evaluates the safety and efficacy of paclitaxel-releasing SeQuent® Please Neo&#xD;
      balloon in the following scenarios: restenosis, bifurcation lesions, small vessel lesions,&#xD;
      diabetes (diffuse disease) and atrial fibrillation. The objective is to determine the success&#xD;
      of the procedure and the preservation of vascular permeability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The preset registry aim is to evaluate the safety and efficacy of paclitaxel-releasing&#xD;
      SeQuent® Please Neo balloon in the following scenarios: restenosis, bifurcation lesions,&#xD;
      small vessel lesions, diabetes (diffuse disease) and atrial fibrillation. The principal&#xD;
      objective is to determine the success of the procedure and the preservation of vascular&#xD;
      permeability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 5, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Target Lesion Revascularization (TLR) with clinical follow-up at 12 months.</measure>
    <time_frame>From baseline to 12 months</time_frame>
    <description>Target Lesion Revascularization (TLR) with clinical follow-up at 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success of balloon dilation.</measure>
    <time_frame>Baseline</time_frame>
    <description>Success of balloon dilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute adverse cardiac events rate (MACE) and and MACE rate accumulated at 12 months.</measure>
    <time_frame>From baseline to 12 months</time_frame>
    <description>MACE rate and MACE rate accumulated at 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Premature follow-up indication</measure>
    <time_frame>From baseline to 12 months</time_frame>
    <description>Premature follow-up indication</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Drug Coating Balloon (DCB), Sequent Please</condition>
  <eligibility>
    <study_pop>
      <textblock>
        25 patients approx per site who fulfill inclusion/exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ISR in a coronary artery with a diameter stenosis of at least 70%, a length of the&#xD;
             stented segment of &lt;25 mm, and a vascular diameter of at least 2.5 and up to 3.5 mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There is no exclusion criteria except those patients with contraindication for&#xD;
             antiplatelet therapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oriol Rodriguez, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germans Trias i Pujol Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oriol Rodriguez, MD, PhD</last_name>
    <phone>+34 93 497 89 89</phone>
    <email>Oriol.Rodriguez@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oriol Rodriguez, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 27, 2020</study_first_submitted>
  <study_first_submitted_qc>July 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Drug coating Balloon (DCB), Sequent Please</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

